Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

NIVROPAN

Class 5Status: Accepted & Advertised
Application Number6410327
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2024-04-30
Proprietor NameNIVRON PHARMA PRIVATE LIMITED
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameRAHUL DHRUVKUMAR LADHANI[33304]
Agent AddressNEAR SS GIRLS COLLEGE,VITHAL NAGAR, GONDIA-441601
Goods And Services Details[CLASS : 5] PHARMACEUTICAL AND MEDICINAL PREPARATIONS included in class 5

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
NIVROPAN5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about NIVROPAN.

What is the status of trademark application 6410327?
The current status of trademark application 6410327 for NIVROPAN is Accepted & Advertised.
What is the trademark class of NIVROPAN?
NIVROPAN is registered under trademark class 5.
Who is the proprietor of NIVROPAN?
The proprietor of NIVROPAN is NIVRON PHARMA PRIVATE LIMITED.
When was trademark application 6410327 filed?
Trademark application 6410327 for NIVROPAN was filed on 2024-04-30.